Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to -$341558.0.

  • Silo Pharma's Change in Accured Expenses fell 2284.18% to -$341558.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$324093.0, marking a year-over-year decrease of 37312.51%. This contributed to the annual value of $633007.0 for FY2024, which is 8657.8% up from last year.
  • As of Q3 2025, Silo Pharma's Change in Accured Expenses stood at -$341558.0, which was down 2284.18% from -$123007.0 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Change in Accured Expenses registered a high of $611165.0 during Q4 2024, and its lowest value of -$470693.0 during Q1 2025.
  • Over the past 5 years, Silo Pharma's median Change in Accured Expenses value was $67721.0 (recorded in 2022), while the average stood at $14439.5.
  • Data for Silo Pharma's Change in Accured Expenses shows a peak YoY increase of 33136153.85% (in 2023) and a maximum YoY decrease of 75182.29% (in 2023) over the last 5 years.
  • Silo Pharma's Change in Accured Expenses (Quarter) stood at $206651.0 in 2021, then tumbled by 31.98% to $140571.0 in 2022, then crashed by 31.12% to $96819.0 in 2023, then skyrocketed by 531.24% to $611165.0 in 2024, then tumbled by 155.89% to -$341558.0 in 2025.
  • Its last three reported values are -$341558.0 in Q3 2025, -$123007.0 for Q2 2025, and -$470693.0 during Q1 2025.